Neta Mostadim, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 463 N Bedford Dr, Beverly Hills, CA 90210 Phone: 310-247-0843 |
Dr. Neda Azizi, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 463 N Bedford Dr, Beverly Hills, CA 90210 Phone: 310-247-0843 Fax: 310-247-0839 |
Dr. Vivian Chu I, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd Ste 601, Beverly Hills, CA 90211 Phone: 310-385-3450 |
Nazly Mehdizadeh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8730 Wilshire Blvd, Ste 202, Beverly Hills, CA 90211 Phone: 916-773-7227 Fax: 916-773-7210 |
Dr. Devorah Sarah Benhaghnazar, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 426 S Doheny Dr, Beverly Hills, CA 90211 Phone: 310-271-6644 |
Farnaz Chaya Yadegar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 N Almont Dr Unit 403, Beverly Hills, CA 90211 Phone: 310-696-1893 |
Dr. Irina Avidon, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd, Ste 601, Beverly Hills, CA 90211 Phone: 310-385-3543 Fax: 310-385-3577 |
Dr. Shaynan Wynne Hill, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd, Suite 601, Beverly Hills, CA 90211 Phone: 310-385-3534 Fax: 310-385-3577 |
Mrs. Diana Mirazic, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 N Canon Dr, Beverly Hills, CA 90210 Phone: 310-273-3561 Fax: 310-273-6725 |
Bahareh Rachel Banafsheh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 433 N Roxbury Dr, Beverly Hills, CA 90210 Phone: 310-271-6123 |
Dr. Tania Houspian Gregorian, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd Ste 601, Beverly Hills, CA 90211 Phone: 310-385-6039 |
Dr. Payam Shabboui, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8536 Wilshire Blvd Ste 101, Beverly Hills, CA 90211 Phone: 310-657-4090 Fax: 310-657-4790 |
Dr. Marjan Kashefi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 433 N Roxbury Dr, Beverly Hills, CA 90210 Phone: 310-271-6123 |
Dr. Omar Noe Gomez Estrada, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 99 N La Cienega Blvd Ste 200, Beverly Hills, CA 90211 Phone: 805-304-9875 |
Kyung Kim, PHARMD Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 9090 Wilshire Blvd Ste 250, Beverly Hills, CA 90211 Phone: 310-967-7602 |
Tiffany Ho, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd Ste 601, Beverly Hills, CA 90211 Phone: 310-248-6374 |
Dr. Jacob Hanaie, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8631 Clifton Way, Beverly Hills, CA 90211 Phone: 818-631-1000 Fax: 877-866-2770 |
Rosette Levy, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 432 N Bedford Dr, Beverly Hills, CA 90210 Phone: 310-213-8884 |
Dr. Andre Khang Nguyen, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 250 N Robertson Blvd, Beverly Hills, CA 90211 Phone: 310-385-3534 |
Julia Marie Tibayan Montoya Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 432 N Bedford Dr, Beverly Hills, CA 90210 Phone: 310-741-4596 Fax: 310-741-4597 |
News Archive
A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
Researchers from the Universities of Nottingham and Leicester are leading the largest ever study of the genetics relating to lung disease.
A large randomized controlled trial of ischemic postconditioning in patients who had experienced the deadliest form of heart attack—ST-segment elevation myocardial infarction (STEMI)—failed to show that this procedure significantly reduces death from any cause or hospitalization for heart failure, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
Women who receive palbociclib (Ibrance) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi Comprehensive Cancer Center researchers.
› Verified 2 days ago